Supplemental Payment Office-administered Drugs Medicaid
| Type | Bill |
|---|---|
| Session | 2018 Regular Session |
| Subjects |
Concerning a supplemental state payment relating to certain office-administered oncology-related drugs for qualified providers under the medical assistance program who experienced a reduction in reimbursement payments in the 2017-18 state fiscal year as a result of the implementation of the federal final rules for covered outpatient drugs, and, in connection therewith, making an appropriation.
Bill Summary:
Medicaid - office-administered oncology drugs - providers - supplemental payment - state-only money - appropriation. The act authorizes a supplemental payment of state-only money to providers under the medicaid program of certain office-administered drugs relating to oncology who experienced a decrease in aggregate reimbursements in the 2017-18 fiscal year as a result of the implementation of the federal department of health and human services final rule for covered outpatient drugs, 81 FR 5169, published in the federal register on February 1, 2016.
The act directs the department of health care policy and financing (department) to distribute a supplemental payment to qualified providers, as defined in the act, and includes provisions for determining the amount of each qualified provider's supplemental payment. The act authorizes the medical services board to adopt rules as necessary.
$754,000 of general fund money is appropriated to the department for the supplemental payment to qualified providers.
(Note: This summary applies to this bill as enacted.)
Related Documents & Information
| Date | Version | Documents |
|---|---|---|
| 04/03/2018 | SA1 |
| Activity | Vote | Documents |
|---|---|---|
| Refer House Bill 18-1330 to the Committee of the Whole and with a recommendation that it be placed on the consent calendar. | The motion passed on a vote of 7-0. | Vote summary |
| Activity | Vote | Documents |
|---|---|---|
| Refer House Bill 18-1330 to the Committee of the Whole. | The motion passed on a vote of 9-4. | Vote summary |
| Date | Calendar | Motion | Vote | Vote Document |
|---|---|---|---|---|
| 04/05/2018 | Third Reading | BILL |
32
AYE
2
NO
1
OTHER
|
Vote record |
| Date | Calendar | Motion | Vote | Vote Document |
|---|---|---|---|---|
| 03/29/2018 | Third Reading | BILL |
45
AYE
18
NO
2
OTHER
|
Vote record |
| Date | Location | Action |
|---|---|---|
| 04/23/2018 | Governor | Governor Signed |
| 04/17/2018 | Governor | Sent to the Governor |
| 04/16/2018 | Senate | Signed by the President of the Senate |
| 04/16/2018 | House | Signed by the Speaker of the House |
| 04/05/2018 | Senate | Senate Third Reading Passed - No Amendments |
| 04/04/2018 | Senate | Senate Second Reading Special Order - Passed - No Amendments |
| 04/03/2018 | Senate | Senate Committee on Appropriations Refer Unamended - Consent Calendar to Senate Committee of the Whole |
| 04/02/2018 | Senate | Introduced In Senate - Assigned to Appropriations |
| 03/29/2018 | House | House Third Reading Passed - No Amendments |
| 03/28/2018 | House | House Second Reading Special Order - Passed - No Amendments |
| 03/27/2018 | House | House Committee on Appropriations Refer Unamended to House Committee of the Whole |
| 03/26/2018 | House | Introduced In House - Assigned to Appropriations |
Prime Sponsor
Sponsor
Co-Sponsor
| Effective Date | Chapter # | Title | Documents |
|---|---|---|---|
| 04/23/2018 | 146 | Supplemental Payment Office-administered Drugs Medicaid |